Benzinga's Top Downgrades

 

  • Berenberg downgraded Bristol-Myers Squibb Co BMY from Buy to Hold. The price target for Bristol-Myers Squibb has been lowered from $80 to $70. Bristol-Myers Squibb shares rose 0.36 percent to $60.80 in pre-market trading.
  • Analysts at Ladenburg Thalmann downgraded Zosano Pharma Corp ZSAN from Buy to Neutral. Zosano Pharma shares fell 2.14 percent to close at $1.37 on Wednesday.
  • Scotia Howard Weil downgraded EQT Corporation EQT from Sector Outperform to Sector Perform. EQT shares dropped 0.84 percent to close at $68.25 on Wednesday.
  • Analysts at Keefe Bruyette & Woods downgraded PHH Corporation PHH from Outperform to Market Perform. PHH shares declined 0.67 percent to $14.82 in pre-market trading.
  • Barrington Research downgraded EPIQ Systems, Inc. EPIQ from Market Perform to Underperform. Epiq Systems shares fell 0.18 percent to $16.31 in pre-market trading.
  • Nomura downgraded Lam Research Corporation LRCX from Buy to Neutral. Lam Research shares declined 4.48 percent to close at $89.11 on Wednesday.
  • Analysts at Morgan Stanley downgraded Lumentum Holdings Inc LITE from Equal-weight to Underweight. The price target for Lumentum Holdings has been raised from $20 to $27. Lumentum Holdings shares rose 0.29 percent to close at $55.72 on Wednesday.
  • Analysts at Evercore ISI Group downgraded Scripps Networks Interactive, Inc. SNI from Buy to Hold. Scripps Networks shares gained 1.04 percent to close at $62.11 on Wednesday.
  • Ladenburg Thalmann downgraded Zosano Pharma Corp ZSAN from Buy to Neutral. Zosano Pharma shares dropped 2.14 percent to close at $1.37 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsInformation TechnologySemiconductor EquipmentTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!